|
Ciltacabtagene autoleucel vs standard of care in patients with functional high-risk multiple myeloma: CARTITUDE-4 subgroup analysis. |
|
|
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Celgene; Janssen; Karyopharm Therapeutics; Sanofi |
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Sanofi |
Speakers' Bureau - Amgen; Sanofi |
Research Funding - Amgen; Bristol-Myers Squibb/Celgene/Juno; Caribou Biosciences (Inst); Janssen |
|
|
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; GlaxoSmithKline; Janssen (Inst); Janssen-Cilag; Karyopharm Therapeutics; Menarini; Novartis; Oncopeptides; Pfizer; Roche; Sanofi; Stemline Therapeutics; Takeda |
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Menarini; Oncopeptides; Roche; Sanofi; Takeda |
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Menarini; Takeda |
|
|
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Janssen (Inst); MERCK (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst) |
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst) |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Magenta Therapeutics; Oncopeptides; Sanofi |
Research Funding - Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Magenta Therapeutics (Inst) |
|
|
Honoraria - Bristol-Myers Squibb; Janssen; Roche |
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Janssen |
Speakers' Bureau - Abbvie; GlaxoSmithKline |
Research Funding - Takeda |
Travel, Accommodations, Expenses - Sanofi Aventis GmbH |
|
|
Research Funding - Atara Biotherapeutics; Janssen; Novartis; Takeda |
|
|
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Sanofi; Takeda |
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Takeda |
Research Funding - Sanofi (Inst) |
|
Carlos Fernandez de Larrea |
Honoraria - Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Pfizer |
Consulting or Advisory Role - Amgen; BeiGene; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Sanofi |
Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst) |
Travel, Accommodations, Expenses - Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Pfizer |
|
|
Consulting or Advisory Role - BMS, Janssen, Roche, Novartis, Gilead, Astellas, Pfizer, Menarini |
Speakers' Bureau - BMS, Janssen, Roche, Novartis, Gilead, Astellas, |
Research Funding - BMS, Astellas, Janssen |
Travel, Accommodations, Expenses - BMS, Janssen, Roche, Novartis, Gilead, Pfizer, |
|
|
No Relationships to Disclose |
|
|
Employment - Johnson & Johnson/Janssen |
Stock and Other Ownership Interests - Johnson & Johnson/Janssen |
Patents, Royalties, Other Intellectual Property - Johnson & Johnson/Janssen |
|
|
Employment - Johnson & Johnson/Janssen |
Leadership - Johnson & Johnson/Janssen (I) |
Stock and Other Ownership Interests - Johnson & Johnson/Janssen |
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen |
|
|
Employment - Haisco Pharmaceutical (I); IQVIA; Janssen |
Research Funding - Haisco Pharmaceutical (I) |
Patents, Royalties, Other Intellectual Property - Haisco Pharmaceutical (I) |
|
|
Employment - Johnson & Johnson/Janssen |
Stock and Other Ownership Interests - Johnson & Johnson/Janssen |
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen |
|
|
Employment - Johnson & Johnson/Janssen |
Stock and Other Ownership Interests - Johnson & Johnson/Janssen |
|
|
Employment - Legend Biotech |
Leadership - Legend Biotech |
Stock and Other Ownership Interests - Legend Biotech |
|
|
Employment - Legend Biotech |
Stock and Other Ownership Interests - Legend Biotech |
|
|
Employment - Legend Biotech |
Stock and Other Ownership Interests - Legend Biotech |
Research Funding - Legend Biotech |
Travel, Accommodations, Expenses - Legend Biotech |
|
|
Employment - Legend Biotech |
Stock and Other Ownership Interests - Legend Biotech |
|
|
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi |
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Kite, a Gilead company; Pfizer; Regeneron; Roche/Genentech; Stemline Therapeutics; Takeda |